Xenon Pharmaceuticals Inc. (XENE)

NGM – Real Time Price. Currency in USD

64.41

+1.19 (1.88%)

Market open: Aug 12, 2026, 11:34 AM EDT

63.21

-0.01 (-0.02%)

Previous after-hours: Aug 11, 2026, 7:50 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

Cost of goods sold

-3M

-4M

Gross Profit

-3M

-4M

Operating expenses (excl. COGS)

-378M

-277M

-211M

-137M

Operating Income

-373M

-279M

-214M

-129M

Non-operating income, total

28M

41M

31M

Pretax income

-345M

-238M

-183M

-125M

Equity in earnings

Taxes

-1M

292K

-118K

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-346M

-234M

-182M

-125M

Discontinued operations

Net income

-346M

-234M

-182M

-125M

Dilution adjustment

Preferred dividends

-437K

Xenon Pharmaceuticals Inc. (XENE)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Xenon Pharmaceuticals Inc. (XENE)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Xenon Pharmaceuticals Inc. (XENE)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Xenon Pharmaceuticals Inc. (XENE)

Income Statement (Annual)

Income Statement (Annual)